Testing a New Injectable Treatment for Schizophrenia

This is an early-stage clinical trial testing a new injectable form of a medication called KarXT for people with schizophrenia. Researchers want to understand how safe this treatment is, how well people tolerate it, and how the body processes it. The goal is to learn whether this long-acting injectable could become a helpful option for managing schizophrenia symptoms.

Many people with schizophrenia struggle with remembering to take daily medications. A long-acting injectable treatment that works for weeks at a time could make it easier for people to stay on their medication and manage their condition more effectively.